Professor High Reads

​

Logline

A new cannabis study drops, Professor High reads it on camera and translates the findings — methodology, conclusions, limitations, and what it actually means for the audience.

​

Concept

This show leverages something the platform already has: the Paper Pipeline, which aggregates fresh cannabis research from PubMed every week. When a relevant new paper publishes, Professor High covers it. The format is simple and repeatable. “This week’s paper. Let’s decode it.” The structure walks the audience through methodology first, findings second, limitations third. The limitations beat is non-negotiable — it is the credibility move that separates the show from the rest of the cannabis-content economy. Then a translation: what does this paper actually change about how a real consumer should think about the plant. Sometimes the answer is “not much yet, but watch this space.” Sometimes it is “this contradicts a thing the industry has been repeating for ten years.” The show positions the brand as research-adjacent, not research-citing. There is a real difference, and the audience can feel it. Skeptic-persona viewers come for the rigor and stay for the voice. The LinkedIn audience treats it as their weekly research digest.

​

Why It Works

​

Format

Total runtime: 6-10 minutes for YouTube. The LinkedIn version is a 4-slide deck. The X version is a 6-tweet thread.

​

Platforms

​

Cadence

Weekly. Whichever paper is most relevant from the week’s Paper Pipeline output. Drop slot is Wednesday morning, 8 AM Central, which puts it in the middle of the workweek when the LinkedIn and professional-research audiences are most active. The show benefits from being responsive rather than scheduled. If a major paper drops on a Friday, the team can pull the slot forward. If nothing notable lands in a given week, the format pivots to “Professor High Re-Reads” — revisiting an older paper that aged well, or aged poorly.

​

Example Episodes

Professor High Reads: “Caryophyllene and CB2 modulation in chronic pain” — what this changes. Walk through a study on caryophyllene’s interaction with the CB2 receptor. The methodology is solid, the sample is small, the implication is real. End with the translation: this is one of the few terpenes with a direct receptor-binding story, and that matters. Professor High Reads: A study claiming THCV reduces appetite — examining the sample size problem. A paper with a striking claim and a sample of 16 participants. Use the limitations beat to teach the audience how to read a sample-size disclosure. Translate: interesting, not actionable yet. Professor High Reads: “Cannabis use disorder” diagnostic criteria revision — what got dropped, what got added. A clinical-criteria paper rather than a chemistry paper. Important for the responsible-consumer audience. Honest about what the revision actually means and what it does not. Professor High Reads: A meta-analysis of 47 cannabis studies — what we actually know vs assume. The high-leverage episode. A meta-analysis lets Professor High zoom out. Use it to mark the line between consensus and conventional wisdom. Professor High Reads: A paper that contradicts last week’s paper — sitting with the contradiction. The honesty episode. Two papers, opposite conclusions, no easy resolution. Model what it looks like to hold uncertainty without collapsing into “we just do not know anything.”

​

Production Notes

The set is fixed. Professor High at his desk, the actual printed paper on the table in front of him, highlighter in hand, lab notebook open. The recurring “Today’s Paper” lower-third carries the full citation in academic format — authors, journal, year, DOI. Notes overlay on screen as he reads, mirroring the highlighter strokes. Closing card is always the same: “Read the full paper at [link]. Back next week.” The link goes to a research page on the website that hosts the paper summary, the citation, and a link to the original PubMed entry. The voice register is rigorous-first, playful-second. This is not the hot-take Professor High. He can be opinionated about a paper, but the opinion comes after the methodology and the limitations, never before. No medical claims. No “this paper proves X.” Always “this paper suggests, in this sample, under these conditions.”

​

Hashtags & Discovery

#cannabisresearch #cannabisscience #pubmed #cannabisindustry #endocannabinoidsystem #cannabisedu #cannabis #420

​

Success Metrics

• Average watch time above 50% (long-form research benchmark)
• LinkedIn slide deck above 3,000 impressions per episode with above 2.5% engagement
• Citations of the show in industry newsletters and trade press
• Newsletter sign-ups attributed to the closing card

​

Pillar

Science Drops. This is the load-bearing show in the science pillar — the weekly cadence that keeps the educational backbone visible.

​

Status

concept

​

Related